David S. Tierney - Apr 8, 2024 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Director
Signature
/s/ David S. Tierney
Stock symbol
CPRX
Transactions as of
Apr 8, 2024
Transactions value $
-$291,750
Form type
4
Date filed
4/10/2024, 05:15 PM
Previous filing
Feb 16, 2024
Next filing
Aug 23, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPRX Common stock, par value $0.001 per share Options Exercise $100K +25K +7.17% $4.01 374K Apr 8, 2024 Direct
transaction CPRX Common stock, par value $0.001 per share Sale -$392K -25K -6.69% $15.68 349K Apr 8, 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPRX Options to purchase common stock Options Exercise $0 +25K +13.97% $0.00 204K Apr 8, 2024 Common Stock 25K $4.01 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold on the open market to fund payment of a personal tax liability and not as a result of any disagreement with the Company.
F2 Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $15.55 to $15.77 per share.
F3 Options vested in three annual tranches beginning on January 2, 2019.